Twist Bioscience Corporation (FRA:0ME)

Twist Bioscience Statistics

Total Valuation

FRA:0ME has a market cap or net worth of EUR 1.57 billion. The enterprise value is 1.45 billion.

Market Cap	1.57B
Enterprise Value	1.45B

Important Dates

The last earnings date was Monday, November 17, 2025.

Earnings Date	Nov 17, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	61.15M
Shares Outstanding	n/a
Shares Change (YoY)	+3.09%
Shares Change (QoQ)	-1.21%
Owned by Insiders (%)	2.13%
Owned by Institutions (%)	111.82%
Float	55.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.89
PB Ratio	3.90
P/TBV Ratio	4.88
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-21.88
EV / Sales	4.47
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-22.47

Financial Position

The company has a current ratio of 3.64, with a Debt / Equity ratio of 0.19.

Current Ratio	3.64
Quick Ratio	3.17
Debt / Equity	0.19
Debt / EBITDA	n/a
Debt / FCF	-1.20
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -16.43% and return on invested capital (ROIC) is -15.19%.

Return on Equity (ROE)	-16.43%
Return on Assets (ROA)	-13.56%
Return on Invested Capital (ROIC)	-15.19%
Return on Capital Employed (ROCE)	-24.75%
Revenue Per Employee	327,837
Profits Per Employee	-67,618
Employee Count	979
Asset Turnover	0.60
Inventory Turnover	7.08

Taxes

In the past 12 months, FRA:0ME has paid 612,804 in taxes.

Income Tax	612,804
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -42.25% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-42.25%
50-Day Moving Average	24.99
200-Day Moving Average	29.49
Relative Strength Index (RSI)	36.82
Average Volume (20 Days)	44

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	6.08

Income Statement

In the last 12 months, FRA:0ME had revenue of EUR 320.95 million and -66.20 million in losses. Loss per share was -1.11.

Revenue	320.95M
Gross Profit	162.79M
Operating Income	-116.13M
Pretax Income	-65.59M
Net Income	-66.20M
EBITDA	-97.42M
EBIT	-116.13M
Loss Per Share	-1.11

Balance Sheet

The company has 198.10 million in cash and 77.19 million in debt, giving a net cash position of 120.91 million.

Cash & Cash Equivalents	198.10M
Total Debt	77.19M
Net Cash	120.91M
Net Cash Per Share	n/a
Equity (Book Value)	403.10M
Book Value Per Share	6.65
Working Capital	205.88M

Cash Flow

In the last 12 months, operating cash flow was -40.59 million and capital expenditures -23.87 million, giving a free cash flow of -64.46 million.

Operating Cash Flow	-40.59M
Capital Expenditures	-23.87M
Free Cash Flow	-64.46M
FCF Per Share	n/a

Margins

Gross margin is 50.72%, with operating and profit margins of -36.18% and -20.63%.

Gross Margin	50.72%
Operating Margin	-36.18%
Pretax Margin	-20.43%
Profit Margin	-20.63%
EBITDA Margin	-30.35%
EBIT Margin	-36.18%
FCF Margin	n/a

Dividends & Yields

FRA:0ME does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.09%
Shareholder Yield	-3.09%
Earnings Yield	-4.21%
FCF Yield	-4.10%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:0ME has an Altman Z-Score of 5.65 and a Piotroski F-Score of 3.

Altman Z-Score	5.65
Piotroski F-Score	3